Researchers have recently hypothesized that patients with myotonic dystrophy (a neuromuscular disease) also have hyperparathyroidism, a syndrome caused by an overactive parathyroid gland. To test this hypothesis, they measured the body’s response to a calcium challenge in patients with myotonic dystrophy, patients with other types of dystrophy (nonmyotonic dystrophy), and normal subjects. One of the biochemical variables they measured was the amount of cAMP excreted by the kidneys. Elevated renal cAMP excretion would be consistent with hyperparathyroidism. The data is contained in the screenshot, where two variables are listed: cAMP – Amount of cAMP excreted by the kidneys, measured in nmol/dL. patient – A factor defining the clinical status of the patient, with three levels: 1, Normal Patient in control group, with no disease. 2, Myotonic Patient with myotonic dystrophy. 3, Nonmyotonic Patient with nonmyotonic dystrophy. (a) Perform an analysis of variance calculation to test the null hypothesis that the mean cAMP levels are the same in all three groups of people. Comment on your results. (b) Perform both (i) a pairwise comparison with a Bonferonni correction and (ii) a Tukey honest significant differences analysis to determine where the significant differences lie. (c) Explain whether you conclude that there is evidence that cAMP excretion is elevated in myotonic dystrophic subjects.
Researchers have recently hypothesized that patients with myotonic dystrophy (a neuromuscular disease) also have hyperparathyroidism, a syndrome caused by an overactive parathyroid gland. To test this hypothesis, they measured the body’s response to a calcium challenge in patients with myotonic dystrophy, patients with other types of dystrophy (nonmyotonic dystrophy), and normal subjects. One of the biochemical variables they measured was the amount of cAMP excreted by the kidneys. Elevated renal cAMP excretion would be consistent with hyperparathyroidism.
The data is contained in the screenshot, where two variables are listed:
- cAMP – Amount of cAMP excreted by the kidneys, measured in nmol/dL.
- patient – A factor defining the clinical status of the patient, with three levels:
- 1, Normal Patient in control group, with no disease.
- 2, Myotonic Patient with myotonic dystrophy.
- 3, Nonmyotonic Patient with nonmyotonic dystrophy.
(a) Perform an analysis of variance calculation to test the null hypothesis that the
(b) Perform both (i) a pairwise comparison with a Bonferonni correction and (ii) a Tukey honest significant differences analysis to determine where the significant differences lie.
(c) Explain whether you conclude that there is evidence that cAMP excretion is elevated in myotonic dystrophic subjects.
Step by step
Solved in 4 steps with 18 images